Webinar, April 22: ADC Performance by Design – From Linker Chemistry to Bioanalytical Insight
SigutLabs, in collaboration with Conscio Group, invites professionals in the biopharmaceutical sector to a focused technical webinar on the drivers of Antibody-Drug Conjugate (ADC) performance.
The session features Alessandro Panattoni, Head of Chemistry at SigutLabs, who will examine the critical role of organic chemistry in optimizing ADC stability and addressing linker-payload incompatibility.
Event Details
Topic: ADC Performance by Design: From Linker Chemistry to DAR and Bioanalytical Insight
Date: Wednesday, April 22, 2:00 PM CET
Registration: Register via Microsoft Teams
Cost: Complimentary
In this session, Alessandro Panattoni will provide practical insights into:
Linker Design: Its influence on key ADC properties, including stability, hydrophilicity, and aggregation behavior.
Conjugation Strategy: How chemistry dictates DAR (Drug-to-Antibody Ratio) control and overall conjugate performance.
Case Study: Practical methods to overcome linker-payload incompatibility through advanced synthetic routes.
Program Overview
The webinar will be hosted by Jiří Raška (CCO, Conscio Group), providing market insights, followed by technical presentations from:
Alessandro Panattoni (SigutLabs): The Organic Chemist’s Role in Enhancing ADC Performance.
Milan Maděra (Conscio Group): Integrated Analytical and Bioanalytical Strategies for Next-Generation Biotherapeutics.
The session will conclude with a live Q&A, offering attendees the opportunity to discuss specific challenges in ADC development.
OUR CASE STUDY
Scale-up to accelerate drug discovery
Our experience helped overcome development hurdles for potential cancer & mental health drugs.
Read moreEmpowering neuro research with pro-N6pA
Sigut Labs scaled up pro-N6pA production, simplifying AMPylation research & boosting accessibility.
Read moreADC development leaps with new linkers
Novel linker design expedited ADC advancement, leading to promising lead compounds faster.
Read moreLincomycin derivative scale-up
Over 30 g of the desired product with exceptional purity was obtained through our optimized procedure.
Read morePurifying 350 kg of vitamin K2 oil
Our innovative scale-up technology helped to reduce the client’s purification process from days to hours.
Read moreOur services
What we excel in so you don’t have to
Custom synthesis
Providing for a custom synthesis of previously reported molecules using described synthetic procedures.
View more
Contract research
Developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry.
View more
Our Experts
Partners & distributors
